The Journal of
Clinical Psychiatry

Volume 63 • 2002 • Supplement 1

Article

Article

Overview of Psychiatric Disorders and the Role of Newer Antidepressants

J Clin Psychiatry 2002;63(suppl 1):3-3

Dennis S. Charney, MD ; Dale R. Grothe, PharmD, BCPP ; Sherry L. Smith, PharmD, BCPP ; Kathleen T. Brady, MD, PhD ; Juliana Kaltsounis-Puckett, PharmD, BCPP ; Clinton W. Wright, PharmD, BCPP ; Lyle K. Laird, PharmD, BCPP ; A. John Rush, MD

Article

Pharmacology of Antidepressants: Focus on Nefazodone

J Clin Psychiatry 2002;63(suppl 1):10-17

C. Lindsay DeVane, PharmD ; Dale R. Grothe, PharmD, BCPP ; Sherry L. Smith, PharmD, BCPP

Article

Six-Year Perspectives on the Safety and Tolerability of Nefazodone

J Clin Psychiatry 2002;63(suppl 1):32-41

David L. Dunner, MD ; Lyle K. Laird, PharmD, BCPP ; John Zajecka, MD ; LaGenia Bailey, PharmD ; Norman Sussman, MD ; Julia L. Seabolt, PharmD

Article

Antidepressant Dosing and Switching Guidelines: Focus on Nefazodone

J Clin Psychiatry 2002;63(suppl 1):42-47

John Zajecka, MD ; Geoffry W. McEnany, RN, PhD, CS ; Kimberly M. Lusk, PharmD, BCPP

Article

Clinical Use of Nefazodone in Major Depression: A 6-Year Perspective. Use of Nefazodone in Major Depression

J Clin Psychiatry 2002;63(suppl 1):18-31

Alan F. Schatzberg, MD ; Maureen R. Prather, PharmD, BCPP ; Martin B. Keller, MD ; A. John Rush, MD ; Lyle K. Laird, Pharm D, BCPP ; Clinton W. Wright, Pharm D, BCPP

Article

Cost Savings With Nefazodone in Treating Depression

J Clin Psychiatry 2002;63(suppl 1):48-51

Robert E. Hales, MD, MBA ; Donald M. Hilty, MD ; Gregory H. Brunson, PharmD